Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner

Gut Microbes. 2020 May 3;11(3):421-432. doi: 10.1080/19490976.2019.1629235. Epub 2019 Jun 16.

Abstract

Patients presenting with Inflammatory bowel disease have been shown to exhibit an altered microbiome in both Crohn's disease and Ulcerative colitis. This shift in the microbial content led us to question whether several of these microbes are important in inflammatory processes present in these diseases and more specifically whether lipopolysaccharides from the gram-negative cell wall differentially stimulates resident cells. We, therefore, investigated the possible contribution of five major species of gram-negative bacteria found to be altered in presence during disease progression and evaluate their pathogenicity through LPS. We demonstrated that LPS from these different species had individual capacities to induce NF-κB and pro-inflammatory IL-8 production from HEK-TLR4 cells in a TLR4 dependent manner. Additional work using human intestinal colonic epithelial cell monolayers (Caco-2) demonstrated that the cells responded to the serotype specific LPS in a distinct manner, inducing many inflammatory mediators such as TNF-α and IL-10 in significantly altered proportions. Furthermore, the permeability of Caco-2 monolayers, as a test for their ability to alter intestinal permeability, was also differentially altered by the serotype specific LPS modulating trans-epithelial electrical resistance, small molecule movement, and tight junction integrity. Our results suggest that specific species of bacteria may be potentiating the pathogenesis of IBD and chronic inflammatory diseases through their serotype specific LPS responses.

Keywords: Endotoxin; Epithelium; Inflammation; Lipopolysaccharides; Toll- like receptor 4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caco-2 Cells
  • Cell Line
  • Cell Survival
  • Cytokines / metabolism*
  • Epithelial Cells / immunology*
  • Epithelial Cells / metabolism*
  • Gram-Negative Bacteria / immunology
  • Gram-Negative Bacteria / pathogenicity
  • Humans
  • Inflammation / immunology*
  • Inflammatory Bowel Diseases / immunology
  • Inflammatory Bowel Diseases / microbiology
  • Interleukin-8 / metabolism
  • Intestines / cytology*
  • Intestines / immunology
  • Lipopolysaccharides / immunology*
  • Lipopolysaccharides / toxicity
  • NF-kappa B / metabolism
  • Permeability
  • Species Specificity
  • Tight Junctions / metabolism
  • Toll-Like Receptor 4 / immunology

Substances

  • CXCL8 protein, human
  • Cytokines
  • Interleukin-8
  • Lipopolysaccharides
  • NF-kappa B
  • TLR4 protein, human
  • Toll-Like Receptor 4

Grants and funding

This study was supported by the Lymphedema Research and Education Program, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary to P.-Y.v.d.W.